Dr. Balevic, et al reply

Stephen J. Balevic; Christoph P. Hornik; Thomas P. Green; Megan E.B. Clowse; Daniel Gonzalez; Anil R. Maharaj; Laura E. Schanberg; Amanda M. Eudy; Geeta K. Swamy; Brenna L. Hughes; Michael Cohen-Wolkowiez

doi:10.3899/jrheum.200681

Dr. Balevic, et al reply

Stephen J. Balevic^*, Christoph P. Hornik, Thomas P. Green, Megan E.B. Clowse, Daniel Gonzalez, Anil R. Maharaj, Laura E. Schanberg, Amanda M. Eudy, Geeta K. Swamy, Brenna L. Hughes, Michael Cohen-Wolkowiez

^*Corresponding author for this work

Pediatrics

Research output: Contribution to journal › Letter › peer-review

1 Scopus citations

Original language	English (US)
Pages (from-to)	1587
Number of pages	1
Journal	Journal of Rheumatology
Volume	47
Issue number	10
DOIs	https://doi.org/10.3899/jrheum.200681
State	Published - Oct 1 2020

ASJC Scopus subject areas

Rheumatology
Immunology and Allergy
Immunology

Access to Document

10.3899/jrheum.200681

Cite this

@article{10f565a74a614357884e565b3ecaa7a2,

title = "Dr. Balevic, et al reply",

author = "Balevic, {Stephen J.} and Hornik, {Christoph P.} and Green, {Thomas P.} and Clowse, {Megan E.B.} and Daniel Gonzalez and Maharaj, {Anil R.} and Schanberg, {Laura E.} and Eudy, {Amanda M.} and Swamy, {Geeta K.} and Hughes, {Brenna L.} and Michael Cohen-Wolkowiez",

note = "Funding Information: Stephen J. Balevic1, MD, MHS Christoph P. Hornik2, MD, PhD Thomas P. Green3, MD, MS Megan E.B. Clowse1, MD, MPH Daniel Gonzalez4, PharmD, PhD Anil R. Maharaj2, PhD Laura E. Schanberg2, MD Amanda M. Eudy1, PhD Geeta K. Swamy5, MD Brenna L. Hughes5, MD, MSc Michael Cohen-Wolkowiez2, MD, PhD 1Department of Rheumatology and Immunology, Duke University School of Medicine, Durham, North Carolina; 2Duke Clinical Research Institute, Durham, North Carolina; 3Department of Pediatrics, Northwestern University, Feinberg School of Medicine, Evanston, Illinois; 4Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; 5Division of Maternal-Fetal Medicine, Department of Obstetrics & Gynecology, Duke University School of Medicine, Durham, North Carolina, USA. Salary and/or research support for this project was provided by the Rheumatology Research Foundation{\textquoteright}s Scientist Development Award, the Thrasher Research Fund, the Childhood Arthritis and Rheumatology Research Alliance/Arthritis Foundation, the Derfner Foundation, NIGMS/NICHD (2T32GM086330-06), NICHD (5R01-HD076676-04, HHSN275201000003I), and a Duke Health/ Private Diagnostic Clinic ENABLE grant. Dr. Schanberg serves on the data and safety monitoring board for Sanofi (sarilumab). Sanofi is a maker of hydroxychloroquine. Dr. Swamy chairs the Independent Data Monitoring Committee for GlaxoSmithKline (RSV vaccine trials). Dr. Cohen-Wolkowiez receives support for research from industry for drug development in adults and children. Address correspondence to Dr. S.J. Balevic, Department of Rheumatology and Immunology, Duke University School of Medicine, 2301 Erwin Road, CHC, T-Level, Durham, NC 27710, USA. Email: stephen.balevic@duke.edu.",

year = "2020",

month = oct,

day = "1",

doi = "10.3899/jrheum.200681",

language = "English (US)",

volume = "47",

pages = "1587",

journal = "Journal of Rheumatology",

issn = "0315-162X",

publisher = "Journal of Rheumatology",

number = "10",

}

TY - JOUR

T1 - Dr. Balevic, et al reply

AU - Balevic, Stephen J.

AU - Hornik, Christoph P.

AU - Green, Thomas P.

AU - Clowse, Megan E.B.

AU - Gonzalez, Daniel

AU - Maharaj, Anil R.

AU - Schanberg, Laura E.

AU - Eudy, Amanda M.

AU - Swamy, Geeta K.

AU - Hughes, Brenna L.

AU - Cohen-Wolkowiez, Michael

N1 - Funding Information: Stephen J. Balevic1, MD, MHS Christoph P. Hornik2, MD, PhD Thomas P. Green3, MD, MS Megan E.B. Clowse1, MD, MPH Daniel Gonzalez4, PharmD, PhD Anil R. Maharaj2, PhD Laura E. Schanberg2, MD Amanda M. Eudy1, PhD Geeta K. Swamy5, MD Brenna L. Hughes5, MD, MSc Michael Cohen-Wolkowiez2, MD, PhD 1Department of Rheumatology and Immunology, Duke University School of Medicine, Durham, North Carolina; 2Duke Clinical Research Institute, Durham, North Carolina; 3Department of Pediatrics, Northwestern University, Feinberg School of Medicine, Evanston, Illinois; 4Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; 5Division of Maternal-Fetal Medicine, Department of Obstetrics & Gynecology, Duke University School of Medicine, Durham, North Carolina, USA. Salary and/or research support for this project was provided by the Rheumatology Research Foundation’s Scientist Development Award, the Thrasher Research Fund, the Childhood Arthritis and Rheumatology Research Alliance/Arthritis Foundation, the Derfner Foundation, NIGMS/NICHD (2T32GM086330-06), NICHD (5R01-HD076676-04, HHSN275201000003I), and a Duke Health/ Private Diagnostic Clinic ENABLE grant. Dr. Schanberg serves on the data and safety monitoring board for Sanofi (sarilumab). Sanofi is a maker of hydroxychloroquine. Dr. Swamy chairs the Independent Data Monitoring Committee for GlaxoSmithKline (RSV vaccine trials). Dr. Cohen-Wolkowiez receives support for research from industry for drug development in adults and children. Address correspondence to Dr. S.J. Balevic, Department of Rheumatology and Immunology, Duke University School of Medicine, 2301 Erwin Road, CHC, T-Level, Durham, NC 27710, USA. Email: stephen.balevic@duke.edu.

PY - 2020/10/1

Y1 - 2020/10/1

UR - http://www.scopus.com/inward/record.url?scp=85092310008&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85092310008&partnerID=8YFLogxK

U2 - 10.3899/jrheum.200681

DO - 10.3899/jrheum.200681

M3 - Letter

C2 - 32451351

AN - SCOPUS:85092310008

SN - 0315-162X

VL - 47

SP - 1587

JO - Journal of Rheumatology

JF - Journal of Rheumatology

IS - 10

ER -

Dr. Balevic, et al reply

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this